Results 41 to 50 of about 17,804 (213)
Diagnóstico e tratamento da doença de Paget óssea [PDF]
Objective:To conduct a literature review on the diagnosis and management of Paget’s disease of bone. Materials and methods:This scientific statement was generated by a request from the Brazilian Medical Association (AMB) to the Brazilian Society of ...
Bandeira, Francisco +8 more
core +3 more sources
Gene expression analyses of candidate genes quantified by PCR from cell lysates of in vitro differentiated osteoclasts and normalized by 18S. (PPT 239 kb)
Laurier, Emilie +4 more
openaire +1 more source
Schematic model showing the suggested mechanism that ZA induces classical activation of macrophages by impairing mitochondrial biofunction and inhibiting mitochondrial clearance to contribute to the pathological process of BRONJ. RAPA‐loaded nanoparticles ZDPR has shown potential in alleviating BRONJ lesions as well as treating osteoporosis or ...
Hang Zhang +10 more
wiley +1 more source
Subtrochanteric Fracture In A Chinese Woman With Paget’s Disease Of Bone And On Long Term Bisphosphonate Therapy: Could It Be An Insufficiency Fracture? [PDF]
Paget’s disease is common in Western countries but is very rare in Chinese populations. Although bisphosphonate has been widely used to treat symptomatic Paget’s disease, prolonged use may be associated with insufficiency fracture. We highlight this rare
CK Lee, P Jeremy, S Simmrat, M Azura
doaj
Background Paget's disease of bone (PDB) disrupts normal bone architecture and causes pain, deformity, deafness, osteoarthritis, and fractures. Genetic factors play a role in PDB and genetic tests are now conducted for research purposes.
McCallum Marilyn +12 more
doaj +1 more source
Gene expression analyses of candidate genes quantified by PCR from cell lysates of in vitro differentiated osteoclasts and normalized by G6PD. (PPT 240 kb)
Laurier, Emilie +4 more
openaire +1 more source
How accurate is your sclerostin measurement?:Comparison between three commercially available sclerostin ELISA kits [PDF]
Sclerostin, bone formation antagonist is in the spotlight as a potential biomarker for diseases presenting with associated bone disorders such as chronic kidney disease (CDK-MBD). Accurate measurement of sclerostin is therefore important.
Fisher, Emily +6 more
core +1 more source
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis
Background Transition from long‐term denosumab to PTH‐analogs or romosozumab might expose patients to the risk of the so‐called rebound phenomenon. Adding romosozumab to denosumab might represent an option in patients experiencing a fracture while on denosumab.
Giovanni Adami +10 more
wiley +1 more source
Practical consensus recommendatons for Paget's disease in breast cancer
Paget's disease of the breast is a rare type of cancer of the nipple–areola complex and that is often associated with an underlying in situ or invasive carcinoma. Diagnosis and treatment of Paget's disease is controversial.
A Gaurav +8 more
doaj +1 more source

